McKinley Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,877
Closed -$756K 162
2022
Q4
$756K Buy
+2,877
New +$771K 0.1% 143
2020
Q1
Sell
-1,698
Closed -$409K 188
2019
Q4
$409K Buy
1,698
+53
+3% +$11.7K 0.03% 177
2019
Q3
$319K Sell
1,645
-103
-6% -$19.8K 0.02% 160
2019
Q2
$322K Sell
1,748
-718
-29% -$129K 0.02% 201
2019
Q1
$468K Sell
2,466
-274
-10% -$52.3K 0.03% 158
2018
Q4
$533K Buy
2,740
+488
+22% +$95.2K 0.04% 152
2018
Q3
$467K Buy
2,252
+551
+32% +$109K 0.03% 160
2018
Q2
$314K Sell
1,701
-12
-0.7% -$2.12K 0.02% 187
2018
Q1
$292K Buy
1,713
+19
+1% +$3.49K 0.02% 195
2017
Q4
$294K Sell
1,694
-521
-24% -$92.2K 0.01% 270
2017
Q3
$413K Buy
2,215
+203
+10% +$36K 0.02% 270
2017
Q2
$347K Sell
2,012
-2,325
-54% -$378K 0.01% 274
2017
Q1
$712K Buy
4,337
+122
+3% +$20.3K 0.03% 266
2016
Q4
$616K Sell
4,215
-53
-1% -$7.98K 0.02% 274
2016
Q3
$712K Buy
4,268
+1,965
+85% +$332K 0.03% 267
2016
Q2
$350K Sell
2,303
-81
-3% -$12.6K 0.02% 282
2016
Q1
$357K Sell
2,384
-8
-0.3% -$1.19K 0.02% 257
2015
Q4
$388K Buy
2,392
+4
+0.2% +$629 0.02% 265
2015
Q3
$330K Sell
2,388
-136
-5% -$21.4K 0.02% 272
2015
Q2
$387K Sell
2,524
-24
-0.9% -$3.85K 0.02% 280
2015
Q1
$407K Sell
2,548
-93
-4% -$14.6K 0.02% 267
2014
Q4
$421K Sell
2,641
-53
-2% -$8.26K 0.02% 264
2014
Q3
$378K Sell
2,694
-24
-0.9% -$3.13K 0.02% 271
2014
Q2
$322K Sell
2,718
-199
-7% -$23K 0.01% 272
2014
Q1
$360K Sell
2,917
-6,679
-70% -$810K 0.02% 314
2013
Q4
$1.09M Buy
9,596
+6,474
+207% +$736K 0.04% 237
2013
Q3
$349K Buy
3,122
+81
+3% +$8.78K 0.02% 316
2013
Q2
$300K Buy
+3,041
New +$316K 0.02% 296

Other funds holding AMGN

McKinley Capital Management's AMGN Position: Q1 2023 in Review

McKinley Capital Management sold out of Amgen (AMGN) in Q1 2023, closing a stake of 2,877 shares — an estimated $756K sold.

McKinley Capital Management first reported a position in AMGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.09M in Q4 2013. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • McKinley Capital Management reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • McKinley Capital Management sold 2,877 Amgen shares in Q1 2023, an estimated $756K.
  • McKinley Capital Management first reported a position in Amgen in Q2 2013 and held it in 28 quarters.
  • McKinley Capital Management's Amgen position peaked at $1.09M in Q4 2013.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on McKinley Capital Management's 13F filing for Q1 2023, filed 11 May 2023.